Aeris Resources Limited (ASX:AIS) Reports Strong HY25 Financial Results
Aeris Resources Limited (ASX:AIS) reports a 257% increase in net profit and strong cash flow in its FY25 half-year results.
Aeris Resources Limited (ASX:AIS) reports a 257% increase in net profit and strong cash flow in its FY25 half-year results.
Connected Minerals Limited (ASX:CML) confirms high-grade uranium mineralisation in its Etango North-East Project, highlighting exploration success and future drilling plans.
Hammer Metals Ltd (ASX:HMX) begins a 2,000m IOCG drilling program at Bullrush Joint Venture with Sumitomo Metal Mining Oceania.
Telix Pharmaceuticals (ASX:TLX) announces FDA acceptance of BLA for TLX250-CDx, targeting kidney cancer imaging with a planned U.S. launch in 2025.
Lynas Rare Earths Ltd (ASX:LYC) reports an 8% revenue increase in H1 2024, alongside key operational milestones and strong safety performance.
OncoSil Medical Ltd (ASX:OSL) achieves significant clinical and financial milestones, expanding its global presence and enhancing its financial position in H1 2025.
Acrux (ASX:ACR) reports A$20 million revenue for FY23-FY24 and announces new US product launches, bolstering its presence in the pharmaceutical market.
Archer Materials Limited (ASX:AXE) improves Biochip’s potassium detection accuracy, advances to human blood testing, and plans regulatory engagements.
Dimerix Limited (ASX:DXB) reports a 113% revenue increase in the half-year ended December 2024, alongside a 93% rise in losses.
Titomic Limited (ASX:TTT) expands US operations by acquiring a Huntsville facility, securing financing, and enhancing manufacturing capabilities.